AIFM2 and lung adenocarcinoma: In this study, we demonstrated that factors related to ferroptosis can be biomarkers for the prognosis of lung adenocarcinoma and provided the basis for a new therapeutic strategy using ferroptosis induction by regulating GPX4 and FSP1 in lung adenocarcinoma cells.